A-1210477

CAS No. 1668553-26-1

A-1210477 ( A1210477 )

Catalog No. M12546 CAS No. 1668553-26-1

A-1210477 is a potent, selective Mcl-1 inhibitor that bind to Mcl-1 (Ki=0.45 nM) to disrupt MCL-1-BIM complexes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 31 In Stock
5MG 50 In Stock
10MG 87 In Stock
25MG 147 In Stock
50MG 259 In Stock
100MG 403 In Stock
500MG 888 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    A-1210477
  • Note
    Research use only, not for human use.
  • Brief Description
    A-1210477 is a potent, selective Mcl-1 inhibitor that bind to Mcl-1 (Ki=0.45 nM) to disrupt MCL-1-BIM complexes.
  • Description
    A-1210477 is a potent, selective Mcl-1 inhibitor that bind to Mcl-1 (Ki=0.45 nM) to disrupt MCL-1-BIM complexes, shows much weaker against Bcl-2 (Ki=132 nM) and Bcl-XL (Ki>660 nM); induces the hallmarks of intrinsic apoptosis and demonstrates single agent killing of multiple myeloma and non-small cell lung cancer cell lines, synergizes with the BCL-2/BCL-XL inhibitor navitoclax to kill a variety of cancer cell lines; also enhances cobimetinib-induced apoptosis in vitro.
  • Synonyms
    A1210477
  • Pathway
    Angiogenesis
  • Target
    Bcl-2
  • Recptor
    Mcl-1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1668553-26-1
  • Formula Weight
    850.04
  • Molecular Formula
    C46H55N7O7S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: < 4.8 mg/mL
  • SMILES
    O=C(C(N1CCN2CCOCC2)=C(CCCOC3=C(C=CC=C4)C4=CC=C3)C5=C1C(C6=C(COC7=CC=C(N8CCN(S(=O)(N(C)C)=O)CC8)C=C7)N(C)N=C6C)=CC=C5)O
  • Chemical Name
    1H-Indole-2-carboxylic acid, 7-[5-[[4-[4-[(dimethylamino)sulfonyl]-1-piperazinyl]phenoxy]methyl]-1,3-dimethyl-1H-pyrazol-4-yl]-1-[2-(4-morpholinyl)ethyl]-3-[3-(1-naphthalenyloxy)propyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Leverson JD, et al. Cell Death Dis. 2015 Jan 15;6:e1590.
2. Xiao Y, et al. Mol Cancer Ther. 2015 Aug;14(8):1837-47.
3. Phillips DC, et al. Blood Cancer J. 2015 Nov 13;5:e368.
4. Karpel-Massler G, et al. Cancer Res. 2017 Jul 1;77(13):3513-3526.
molnova catalog
related products
  • SMBA1

    A potent, and selective Bax agonist (Ki=43.3 nM) that induces conformational changes in Bax by blocking S184 phosphorylation.

  • Dehydrocavidine

    Dehydrocavidine has antitumor activity, it inhibits MCF-7 cell proliferation by inducing apoptosis mediated by regulating Bax/Bcl-2, activating caspases as well as cleaving PARP.

  • Paederosidic acid

    Paederosidic acid has significant anti-tumor anticonvulsant and sedative effects. Paederosidic acid increases brain gamma-aminobutyric acid and decreases glutamic acid in the brain and it up-regulates expressions of GAD 65 may be a promising future therapeutic agent for treatment of epilepsy.